IP Library › Granted Patent US 8,541,375
Granted Patent B2
US 8,541,375 · App. 13/328,284 · Granted Sep 24, 2013

Glycopeptide phosphonate derivatives

Inventor: Michael R. Leadbetter (San Leandro, CA)
Assignee: Theravance, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,541,375
App. No.
13/328,284
Granted
Sep 24, 2013
Kind
B2
Abstract

Disclosed are glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.

Claims (4)

1. A compound of the formula:

or a pharmaceutically-acceptable salt thereof.

2. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of the formula:

or a pharmaceutically-acceptable salt thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033181/0646 →
Continuity (9)
Continuation 12715554 · Mar 2, 2010
Continuation 11977429 · Oct 24, 2007
Continuation 11584908 · Oct 23, 2006
Continuation 11265570 · Nov 2, 2005
Continuation 11037934 · Jan 18, 2005
Continuation 10669778 · Sep 24, 2003
Continuation 09847042 · May 1, 2001
Provisional Application 60213410 · Jun 22, 2000
Related Publication 20120283195A1 · Nov 8, 2012